Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35777029)

  • 1. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
    Ge L; Sun Q; Xia L; Xu X
    Medicine (Baltimore); 2022 Jul; 101(26):e29802. PubMed ID: 35777029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of NUF2 in breast cancer and its clinical significance].
    Sun J; Chen J; Wang Z; Deng Y; Liu L; Liu X
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):591-597. PubMed ID: 31140425
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Xie X; Jiang S; Li X
    Front Oncol; 2021; 11():621373. PubMed ID: 33767990
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
    Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
    Front Oncol; 2021; 11():656509. PubMed ID: 34178642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.
    Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
    Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
    Xu W; Wang Y; Wang Y; Lv S; Xu X; Dong X
    Int J Mol Med; 2019 Aug; 44(2):390-404. PubMed ID: 31198978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 8. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
    He XY; Zhao J; Chen ZQ; Jin R; Liu CY
    Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANP32E contributes to gastric cancer progression via NUF2 upregulation.
    Zhu X; Zou Y; Wu T; Ni J; Tan Q; Wang Q; Zhang M
    Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35795988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the expression of SLC30A family genes and prognosis in human gastric cancer.
    Guo Y; He Y
    Sci Rep; 2020 Oct; 10(1):18352. PubMed ID: 33110097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUF2 Promotes Breast Cancer Development as a New Tumor Stem Cell Indicator.
    Deng Y; Li J; Zhang Y; Hu H; Wan F; Min H; Zhou H; Gu L; Liao X; Zhou J; Zhou J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers.
    Jiang X; Jiang Y; Luo S; Sekar K; Koh CKT; Deivasigamani A; Dong Q; Zhang N; Li S; Hao F; Goh BKP; Ooi LL; Wang Y; Hui KM
    Cancer Res Treat; 2021 Oct; 53(4):944-961. PubMed ID: 33421974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer.
    Lv S; Xu W; Zhang Y; Zhang J; Dong X
    Int J Oncol; 2020 Dec; 57(6):1358-1367. PubMed ID: 33173994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer.
    Guo F; Kong WN; Feng YC; Lv J; Zhao G; Wu HL; Ai L; Zhou X; Cai XL; Sun W; Ma XM
    Technol Cancer Res Treat; 2020; 19():1533033820970688. PubMed ID: 33167799
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Jiang F; Huang X; Yang X; Zhou H; Wang Y
    Front Oncol; 2022; 12():795971. PubMed ID: 35814368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
    Liu J; Liu Z; Zhang X; Gong T; Yao D
    BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
    Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
    Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.